Follow
Xingyao He
Xingyao He
Verified email at northwestern.edu
Title
Cited by
Cited by
Year
Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
FJ Cordero, Z Huang, C Grenier, X He, G Hu, RE McLendon, SK Murphy, ...
Molecular Cancer Research 15 (9), 1243-1254, 2017
1562017
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
L Wang, Z Zhao, PA Ozark, D Fantini, SA Marshall, EJ Rendleman, ...
Nature medicine 24 (6), 758-769, 2018
1482018
Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma
H Katagi, N Louis, D Unruh, T Sasaki, X He, A Zhang, Q Ma, A Piunti, ...
Clinical cancer research 25 (18), 5572-5583, 2019
612019
Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
ST Sredni, AW Bailey, A Suri, R Hashizume, X He, N Louis, T Gokirmak, ...
Oncotarget 8 (67), 111190, 2017
282017
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model
N Louis, S Liu, X He, DC Drummond, CO Noble, S Goldman, S Mueller, ...
Journal of Neuro-oncology 136, 475-484, 2018
232018
Therapeutic targeting of EZH2 and BET BRD4 in pediatric rhabdoid tumors
Y Ishi, Y Zhang, A Zhang, T Sasaki, A Piunti, A Suri, J Watanabe, K Abe, ...
Molecular cancer therapeutics 21 (5), 715-726, 2022
152022
Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma
T Sasaki, J Watanabe, X He, H Katagi, A Suri, Y Ishi, K Abe, M Natsumeda, ...
Journal of neurosurgery 138 (6), 1570-1579, 2022
22022
ATRT-02. THERAPEUTIC TARGETING OF EZH2 AND BET BRD4 IN AT/RT
A Zhang, A Piunti, P Ozark, X He, H Katagi, T Sasaki, K Laurie, ...
Neuro-Oncology 21 (Suppl 2), ii63, 2019
22019
Dipg-33. New Therapeutic Approach for Brainstem Glioma: Intranasal Delivery of Nanoliposomal Sn-38
X He, N Louis, H Katagi, P Zhang, I Balyasnikova, C Horbinski, ...
Neuro-oncology 20 (suppl_2), i55-i55, 2018
22018
PDTM-28. TARGETED INHIBITION OF EZH2 AND BET BROMODOMAIN PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS
A Piunti, M Morgan, E Bartom, N Louis, X He, A Zhang, C Horbinski, ...
Neuro-Oncology 19 (suppl_6), vi196-vi196, 2017
22017
PDTM-42. TARGETED INHIBITION OF BET BROMODOMAIN AND JMJD3 PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
H Katagi, A Zhang, GT Blyth, FD Eckerdt, PA Ozark, L Zou, X He, ...
Neuro-Oncology 20 (Suppl 6), vi212, 2018
2018
RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
N Louis, X He, D Unruh, A Piunti, L Zou, P Ozark, X Tianc, V Gorbunova, ...
NEURO-ONCOLOGY 20, 61-62, 2018
2018
DIPG-24. TARGETED INHIBITION OF JMJD3 AND BET BROMODOMAIN PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS
H Katagi, N Louis, X He, K Loughlin, A Zhang, P Ozark, C Horbinski, ...
Neuro-Oncology 20 (Suppl 2), i53, 2018
2018
Radiation DNA damage repair inhibition by GSK-J4 in DIPG
N Louis, X He, A Piunti, A Saratsis, R Lulla, J Fangusaro, C Horbinski, ...
JOURNAL OF NEUROSURGERY 128 (4), 77-78, 2018
2018
PDTM-44. RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
N Louis, X He, A Piunti, M Morgan, D Unruh, A Saratsis, R Lulla, ...
Neuro-Oncology 19 (suppl_6), vi199-vi199, 2017
2017
NEW THERAPEUTIC APPROACH FOR BRAINSTEM GLIOMA: INTRANASAL DELIVERY OF NANOLIPOSOMAL SN-38
X He, N Louis, P Zhang, I Balyasnikova, C Horbinski, S Goldman, ...
NEURO-ONCOLOGY 19, 269-269, 2017
2017
DIPG-36. NOVEL THERAPEUTIC APPROACHES USING NANOLIPOSMAL SN-38 FOR THE TREATMENT OF HUMAN BRAINSTEM GLIOMA
X He, N Louis, R Hashizume, P Zhang, I Balyasnikova, C Horbinski, ...
Neuro-Oncology 19 (Suppl 4), iv13, 2017
2017
DIPG-28. RADIATION DNA DAMAGE REPAIR INHIBITION BY GSK-J4 INDUCED CHROMATIN COMPACTION IN DIPG
N Louis, X He, A Plunti, A Saratsis, R Lulla, J Fangusaro, C Horbinski, ...
Neuro-Oncology 19 (Suppl 4), iv10, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–18